org/articles/3119-esophageal-stricture-benign[iii] The WallFlex
Esophageal Stent is not approved for removal from malignant strictures
The WallFlex
Esophageal Stent allows physicians to re-establish patency (openness) of the esophagus, enabling resumption of oral intake.
The Evolution Fully Covered Stent builds on technology introduced with the Evolution([R]) Controlled Release
Esophageal Stent, which received 510(k) clearance in May 2008.
Typically, an
esophageal stent is used in the treatment of esophageal cancer patients whose condition has advanced beyond surgical treatment options.
Dasari and colleagues summarized 27 case series using
esophageal stents in patients with esophageal anastomotic leaks and benign perforations.
With the addition of the AERO(TM) Hybrid Tracheobronchial Stent System to its product line, Alveolus now successfully has its total current portfolio, which are FDA and CE Mark cleared, including pulmonary stents,
esophageal stents (ALIMAXX-E(TM)), guidewires (MAXXWIRE(TM)), and stent sizing devices (AEROSIZER(TM)).
Our WallFlex Biliary Stents complement our extensive line of enteral and
esophageal stents to offer a complete range of treatment options to palliate and treat patients with gastrointestinal diseases.
